TheraRadar
← Back
Data updated: Mar 29, 2026

Baxter

Infectious DiseaseCardiovascularOncology
Specialty

Baxter is a specialty pharmaceutical company focused on Infectious Disease, Cardiovascular, Oncology. Key products include PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE.

1951
Since
304
Drugs
-
Trials
487
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 24%
12 drugs
Cardiovascular 22%
11 drugs
Oncology 19%
9 drugs Phase 1: 1
Dermatology 18%
9 drugs
Ophthalmology 16%
8 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...